In the GSE227835 dataset, which includes 10 MG patients (AChR antibody‐positive) and 10 control individuals, a comparative analysis confirmed significantly reduced IGF1R expression in MG patients (p < 0.05) (Figure 4C,D). This evidence concerns the gene IGF1R and myasthenia gravis.